A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour

Summary

This study is a multicentre, open phase I clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-7058.

Timeline

Start

2024-06-06

Primary completion

2026-06

Completion

2026-06

Drugs

Indications